Clinical Trials
All Clinical Trials - Page 41 of 52
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT01592279Phase 4Unknown
GLP-1 Analogue Treatment in Uncontrolled Type 1 Diabetic Patients
Liraglutide
- NCT01624259Phase 3Completed
A Study Comparing the Effect of Dulaglutide With Liraglutide in Type 2 Diabetes
Liraglutide
- NCT01715428N/ACompleted
Liraglutide and Cardio-Metabolic Risk Markers
Liraglutide
- NCT01484873Phase 2Completed
Weight Loss Study for Patients With Obesity Due to Craniopharyngioma or Other Brain Tumor
Exenatide
- NCT01788462N/AWithdrawn
Egrifta Replacement and Sleep Disordered Breathing
Tesamorelin
- NCT01605136Phase 3Completed
Phase III Confirmatory Study in Erythropoietic Protoporphyria
Afamelanotide
- NCT02328924Phase 4Completed
There is a Value of Luteinizing Hormone Predictive of in Vitro Fertilization Treatment Outcome in Antagonist Protocols?
Gonadorelin
- NCT01546987Phase 3Completed
Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer
Gonadorelin
- NCT02516657Phase 3Completed
Liraglutide in Adolescents With Type 1 Diabetes
Liraglutide
- NCT01550653Phase 1Completed
Liraglutide Effects on Memory in Healthy Subjects
Liraglutide
- NCT01595789Phase 4Completed
The Effect of Liraglutide on the Treatment of Coronary Artery Disease and Type 2 Diabetes
Liraglutide
- NCT01593137Phase 4Withdrawn
A Long-term Trial to Compare the Effects of Liraglutide and Sulphonylurea (Glimepiride) Both in Combination With Metformin on Clinical, Endothelial and Image Markers of Cardiovascular Risk in Patients With Type 2 Diabetes
Liraglutide
- NCT01596504Phase 2Completed
Pharmacodynamic Effects of Lixisenatide Compared to Liraglutide in Patients With Type 2 Diabetes Not Adequately Controlled With Insulin Glargine With or Without Metformin
Liraglutide
- NCT01572740Phase 3Completed
Efficacy and Safety of Liraglutide in Combination With Insulin Therapy Compared to Insulin Alone in Japanese Subjects With Type 2 Diabetes
Liraglutide
- NCT01572909Phase 2Completed
Evaluation of Myocardial Effects of MTP-131 for Reducing Reperfusion Injury in Patients With Acute Coronary Events
Elamipretide
- NCT01595334N/AUnknown
Study on Influence of Leutinizing Hormone (LH) on Oocyte Maturity
Gonadorelin
- NCT01606709Phase 4Terminated
Gene Expression Profile After Gonadotropin Releasing Hormone (GnRH) Agonist Trigger of Oocyte Maturation
Gonadorelin
- NCT01565265N/ACompleted
Comparing Ovarian Stimulation for Assisted Reproduction With Two Different Forms of Pituitary Suppression
Gonadorelin
- NCT01584232Phase 3Completed
A Study of Dulaglutide in Japanese Participants With Type 2 Diabetes Mellitus
Dulaglutide
- NCT01206101Phase 2Terminated
Efficacy and Safety of Liraglutide in Subjects With Type 1 Diabetes Undergoing Islet Cell Transplantation
Liraglutide
- NCT01452685Phase 2Completed
A Long-term Extension Study of TAK-385 in the Treatment of Endometriosis
Gonadorelin
- NCT01581359Phase 4Completed
The Effect of Pre-treatment With GnRH Analogues Prior in Vitro Fertilization in Patients With Endometriosis
Gonadorelin
- NCT01558271Phase 3Completed
A Study of LY2189265 in Japanese Participants With Type 2 Diabetes Mellitus
Liraglutide
- NCT01562678Phase 4Completed
Liraglutide in Obesity and Diabetes: Identification of CNS Targets Using fMRI
Liraglutide
- NCT01524770Phase 1Completed
A Study to Compare the Effect of Giving Dulaglutide Using an Auto-injector Versus a Manual Syringe
Dulaglutide
- NCT01444898N/ACompleted
Effects of Exenatide on Overweight Adolescents With Prader-Willi Syndrome
Exenatide
- NCT01590433Phase 4Completed
Weight Loss With Exenatide Treatment
Exenatide
- NCT01546454N/ACompleted
Relationship Between the Menstrual Cycle and Heart Disease in Women
Gonadorelin
- NCT01782261Phase 2Completed
Incretin Effect on the Immunological Phenotype
Liraglutide
- NCT01542242Phase 4Terminated
Liraglutide Use in Prader-Willi Syndrome
Liraglutide
- NCT01536665Phase 1Completed
The Effect of Liraglutide Adjunct to Insulin on Glucagon Response to Hypoglycaemia in Subjects With Type 1 Diabetes
Liraglutide
- NCT01392898N/AUnknown
Liraglutide and Insulin Therapy in Patients With Type 2 Diabetes
Liraglutide
- NCT01512108Phase 3Completed
Safety and Efficacy of Liraglutide in Combination With an OAD in Subjects With Type 2 Diabetes Insufficiently Controlled on OAD Alone
Liraglutide
- NCT01511393N/AEnrolling By Invitation
An Active Surveillance Program for Cases of Medullary Thyroid Carcinoma (MTC)
Semaglutide
- NCT01518985Phase 1Completed
The Impact of Intravenous Bendavia™ on Endothelial Reactivity Dysfunction in Cigarette Smoking
Elamipretide
- NCT01519349Phase 1Completed
Follistatin Gene Transfer to Patients With Becker Muscular Dystrophy and Sporadic Inclusion Body Myositis
Follistatin
- NCT01492972Phase 3Recruiting
Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer
Gonadorelin
- NCT01491971Phase 2Completed
Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer
Gonadorelin
- NCT01425580Phase 2Completed
Liraglutide and Heart Failure in Type 2 Diabetes
Liraglutide
- NCT01505673Phase 4Completed
Adding Liraglutide to High Dose Insulin: Breaking the Cycle
Liraglutide
- NCT01232946N/ACompleted
Cooperation of Insulin and GLP-1 on Myocardial Glucose Uptake
Liraglutide
- NCT01518101Phase 4Completed
Vildagliptin Versus Liraglutide - Patient Preference After Receiving Both Medications
Liraglutide
- NCT01687582N/ACompleted
Effect of GLP-1 Analogs on Psoriasis in Type 2 Diabetic Patients
Liraglutide
- NCT02104037N/ACompleted
Liraglutide in Spinal Fluid
Liraglutide
- NCT01469351N/ACompleted
Identifying Potential Effects of Liraglutide on Degenerative Changes
Liraglutide
- NCT01855490Phase 1Completed
Study of the Acute Metabolic Effect of Exenatide in Type 1 Diabetes
Exenatide
- NCT01554618Phase 3Completed
Safety and Efficacy Study of Exenatide Once Weekly in Adolescents With Type 2 Diabetes
Exenatide
- NCT03923218N/ACompleted
Effects of Smoking and Vitamin D3 on the Levels of Human Cathelicidin Peptide LL-37
Ll-37
- NCT02382471Phase 4Completed
Assessing the Effects of Omega-3 Supplementation on Some Serum BDNF، Follistatin، Irisin Levels in Men With CAD
Follistatin
- NCT02417103Phase 3Terminated
Pretreatment of Patients Expecting Bariatric Surgery With the GLP-1 Analogon Liraglutid
Liraglutide